Vericel Corp reports results for the quarter ended in September 30 - Earnings Summary

Vericel

07/11/2024 15:07

* Vericel Corp  VCEL.OQ  reported a quarterly adjusted loss
of 2
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -8 cents.  The mean expectation of seven analysts for the
quarter was for a loss of 5 cents per share. Wall Street
expected results to range from -8 cents to -2 cents per share.
    * Revenue rose 27% to $57.91 million from a year ago;
analysts
expected $55.20 million. 
    * Vericel Corp's reported EPS for the quarter was a loss
of 2
cents​.
    * The company reported a quarterly loss of $901 thousand.
    * Vericel Corp shares had risen by 13.7% this quarter and
gained 34.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Vericel Corp is
57.00 
This summary was machine generated from LSEG data November 7 at
03:07 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.05          -0.02          Beat
 Jun. 30 2024      -0.08          -0.10          Missed
 Mar. 31 2024      -0.11          -0.08          Beat
 Dec. 31 2023      0.17           0.26           Beat